AngioDynamics Inc.

NASDAQ: ANGO · Real-Time Price · USD
8.77
0.04 (0.46%)
At close: Aug 15, 2025, 3:47 PM

AngioDynamics Income Statement

Financials in USD. Fiscal year is June - May.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending May 31, 2025 Feb 28, 2025 Nov 30, 2024 Aug 31, 2024 May 31, 2024 Feb 29, 2024 Nov 30, 2023 Aug 31, 2023 May 31, 2023 Feb 28, 2023 Nov 30, 2022 Aug 31, 2022 May 31, 2022 Feb 28, 2022 Nov 30, 2021 Aug 31, 2021 May 31, 2021 Feb 28, 2021 Nov 30, 2020 Aug 31, 2020
Revenue
80.16M 72M 72.84M 67.49M 70.98M 75.18M 79.07M 78.68M 91.07M 80.71M 85.43M 81.54M 87M 73.97M 78.28M 76.97M 76.84M 71.18M 72.77M 70.22M
Cost of Revenue
40.53M 35.74M 35.5M 33.34M 35.04M 42.61M 38.81M 38.62M 44.72M 40.21M 40.35M 39.23M 40.54M 35.39M 37.73M 36.83M 34.52M 32.65M 32.6M 34.45M
Gross Profit
39.63M 36.26M 37.34M 34.15M 35.94M 32.57M 40.26M 40.06M 46.36M 40.5M 45.08M 42.3M 46.45M 38.58M 40.55M 40.14M 42.32M 38.53M 40.17M 35.76M
Operating Income
-3.63M -6.65M -5.07M -8.71M -5.8M -11.6M -13.12M 35.03M -2.56M -5.33M -3.66M -7.51M -4.34M -3.02M -8.68M -8.1M -21.59M -3.74M -4.84M -5.12M
Interest Income
3K 135K 234K 606K 567K 394K 534K 119K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-6.11M -4.41M -10.85M -12.66M -14.14M -199.74M -12.62M 34.86M -21.86M -9.66M -9.05M -13.86M -6.72M -5.76M -8.86M -8.61M -21.94M -4.13M -5.17M -4.81M
Net Income
-6.05M -4.41M -10.74M -12.8M -13.45M -187.74M -29.05M 45.88M -21.47M -9.48M -8.49M -13M -6.27M -4.96M -8.35M -6.97M -19.47M -3.54M -4.27M -4.27M
Selling & General & Admin
36.67M 35.99M 35.98M 36.58M 35.02M 35.98M 34.75M 38.22M 36.52M 34.24M 36.84M 36.64M 37.94M 29.14M 33.28M 33.39M 32.95M 28.62M 29.39M 26.26M
Research & Development
6.59M 6.91M 6.43M 6.29M 6.72M 8.19M 8.66M 7.94M 7.86M 6.85M 6.84M 8.33M 7.87M 7.28M 8.2M 7.39M 9.1M 8.56M 9.71M 9.01M
Other Expenses
n/a n/a n/a n/a n/a 191.59M 9.97M -41.13M 4.41M 4.74M 4.81M 4.84M 4.85M 4.89M -10K -352K -167K -163K -102K 524K
Operating Expenses
43.26M 42.91M 42.41M 42.87M 41.75M 235.76M 53.38M 5.03M 48.79M 45.84M 48.49M 49.81M 50.66M 41.32M 46.37M 45.6M 46.35M 41.48M 43.7M 40.22M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a 901K 736K 684K 381K 185K 173K 174K 156K 185K 226K 235K 215K
Selling & Marketing Expenses
26.44M 25.5M 25.59M 25.61M 24.58M 25.41M 25.46M 27.37M 26.29M 25.41M 26.01M 26.54M 26.83M 20.42M 23.61M 24.45M 23.82M 19.61M 20.17M 17.7M
Cost & Expenses
83.79M 78.65M 77.92M 76.2M 85.43M 275.08M 92.19M 43.65M 93.5M 86.04M 88.84M 89.05M 91.2M 76.7M 84.1M 82.44M 80.88M 74.13M 76.29M 74.68M
Income Tax Expense
-60K -2K -110K 133K -692K -12M 16.43M -11.02M -398K -179K -565K -853K -455K -799K -512K -1.64M -2.47M -583K -905K -545K
Shares Outstanding (Basic)
40.98M 40.85M 40.92M 40.65M 40.43M 40.23M 40.22M 39.84M 39.61M 39.51M 39.49M 39.3M 39.15M 38.14M 39.05M 38.73M 38.52M 38.36M 38.33M 38.16M
Shares Outstanding (Diluted)
40.98M 40.85M 40.92M 40.65M 40.43M 40.23M 40.22M 39.97M 39.61M 39.51M 39.49M 39.3M 39.16M 39.09M 39.05M 38.73M 38.52M 38.36M 38.33M 38.16M
EPS (Basic)
-0.15 -0.11 -0.26 -0.31 -0.33 -4.67 -0.72 1.15 -0.54 -0.24 -0.21 -0.33 -0.16 -0.13 -0.21 -0.18 -0.51 -0.09 -0.11 -0.11
EPS (Diluted)
-0.15 -0.11 -0.26 -0.31 -0.33 -4.67 -0.72 1.15 -0.54 -0.24 -0.21 -0.33 -0.16 -0.13 -0.21 -0.18 -0.51 -0.09 -0.11 -0.11
EBITDA
-277K 1.91M -3.98M -5.88M -7.32M -4.08M -26K -3.04M -12.81M 2.51M 4.41M -5.2M 1.75M 2.44M -1.41M -853K -14.63M 2.48M 1.07M 2.12M
EBIT
-6.11M -4.41M -10.85M -12.66M -5.8M -11.6M -6.71M -9.73M -20.96M -5.33M -3.41M -13.48M -6.54M -5.58M -8.69M -8.45M -21.75M -3.9M -4.94M -4.6M
Depreciation & Amortization
5.83M 6.32M 6.86M 6.79M 6.82M 7.52M 6.68M 6.69M 8.16M 8.47M 8.45M 8.28M 8.28M 8.02M 7.89M 7.6M 7.12M 6.38M 6.44M 6.58M